March 1st, 2019
•Here, we present a protocol to generate pseudotyped particles in a BSL-2 setting incorporating the spike protein of the highly pathogenic viruses Middle East respiratory syndrome and severe acute respiratory syndrome coronaviruses. These pseudotyped particles contain a luciferase reporter gene allowing quantification of virus entry into target host cells.
Related Videos
Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization
Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
A Novel Feeder-free System for Mass Production of Murine Natural Killer Cells In Vitro
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Highly Efficient Transfection of Primary Macrophages with In Vitro Transcribed mRNA
Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin
Double Labeling Immunofluorescence using Antibodies from the Same Species to Study Host-Pathogen Interactions
Copyright © 2024 MyJoVE Corporation. 판권 소유